van der Horst, E. H., Murgia, M., Treder, M., & Ullrich, A. (2005). Anti-HER-3 MAbs inhibit HER-3-mediated signaling in breast cancer cell lines resistant to anti-HER-2 antibodies. International Journal of Cancer, 115(4), 519-527.